Zhengdeng Lei, PhD

Zhengdeng Lei, PhD

2009 - Present Research Fellow at Duke-NUS, Singapore
2007 - 2009 High Throughput Computational Analyst, Memorial Sloan-Kettering Cancer Center, New York
2003 - 2007 PhD, Bioinformatics, University of Illinois at Chicago

Monday, April 23, 2012

mesenchymal/invasive

Loss of PTEN expression (e.g. mutation/LOH) in mesenchymal/invasive subtype???
Targeting mTORC2 in mesenchymal cancer cells????
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)